Trials / Completed
CompletedNCT02566291
Observational Study With Investigation of Two Second Generation Laryngeal Masks
Supraglottic Airways LMA Supreme and Ambu AuraGain in Clinical Practice: a Prospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 364 (actual)
- Sponsor
- Johannes Gutenberg University Mainz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.
Detailed description
After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Success | Success rate and time for insertion |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-01-01
- Completion
- 2015-03-01
- First posted
- 2015-10-02
- Last updated
- 2017-01-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02566291. Inclusion in this directory is not an endorsement.